5-氮杂胞苷通过B细胞表观遗传调控IgA应答改善IgA肾病
本研究探讨RNA 5-甲基胞嘧啶(5mC)修饰在IgA肾病发病中的作用。在miR-23b−/−和川崎病小鼠模型中,抑制5mC修饰可降低血清IgA水平并减轻IgA肾病样肾损害,而增加5mC修饰则加重表型。机制上,TRDMT1介导的RNA 5mC甲基化通过影响AID活性和IgA类别转换重组调控IgA合成,5-氮杂胞苷抑制5mC可改善疾病进展。
要点
- 抑制RNA 5mC修饰可降低血清IgA并减轻小鼠IgA肾病样病变。
- TRDMT1介导的RNA 5mC甲基化调控B细胞IgA类别转换重组。
- 5-氮杂胞苷通过抑制RNA 5mC修饰改善IgA肾病进展。
核心结论
- TRDMT1诱导的RNA 5mC甲基化调控IgA类别转换,5-氮杂胞苷抑制RNA 5mC可改善IgA肾病进展。
研究设计与样本
- 使用miR-23b−/−和干酪乳杆菌细胞壁提取物诱导的川崎病小鼠,给予5-氮杂胞苷处理。
- 使用Trdmt1−/−、Trdmt1−/−/miR-23b−/−、Aid−/−及Aid−/−/miR-23b−/−小鼠。
主要发现
- miR-23b下调TRDMT1表达,减少B细胞中5mC RNA修饰和IgA合成。
- 抑制5mC RNA修饰使miR-23b−/−和川崎病小鼠血清IgA正常化并减轻IgA肾病样肾病进展。
- Trdmt1−/− miR-23b−/−小鼠未发生系膜IgA和C3沉积。
- 增加5mC RNA修饰导致IgA肾病表型加重。
- miR-23b调控血清IgA和IgA肾病样病变可能通过B细胞中TRDMT1驱动的5mC RNA修饰,损害AID活性和IgA类别转换重组。
临床怎么用
- 靶向TRDMT1或RNA 5mC修饰可能成为IgA肾病的潜在治疗策略。
- 5-氮杂胞苷在动物模型中显示可改善IgA肾病样病变,但临床转化需进一步研究。
局限性
- 研究主要基于小鼠模型,人体数据缺乏。
- 5-氮杂胞苷的作用机制和长期安全性未在IgA肾病患者中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Dysregulated IgA production plays a key role in the pathogenesis of IgA nephropathy. Increased 5-methylcytosine modification, an epigenetic regulatory mechanism, exaggerated IgA nephropathy phenotype in mice. Conversely, inhibition of 5-methylcytosine modification ameliorated progression of IgA nephropathy–like kidney disease in mice. BACKGROUND: IgA nephropathy is an important global cause of kidney failure. Dysregulation of IgA production is believed to play a key role in IgA nephropathy pathogenesis; however, little is known about the epigenetic mechanisms, such as RNA 5-methylcytosine (5mC) modification, in regulating IgA synthesis. METHODS: To decipher the role of RNA 5mC in regulation of IgA class switch, the microRNA (miR)-23b−/− and Lactobacillus casei (Chinese Industrial Microbial Culture Collection Center) cell wall extract–induced Kawasaki disease mice were treated with 5-azacytidine. Trdmt1−/− and double Trdmt1−/−/miR-23b−/− mice and Aid−/− mice or Aid−/−/miR-23b−/− mice were also used. RESULTS: We showed that miR-23b downregulated expression of Transfer RNA Aspartic Acid Methyltransferase 1 and consequently reduced 5mC (m5C) RNA modification and IgA synthesis in B cells. Inhibition of m5C RNA modification normalized serum IgA levels and ameliorated progression of the IgA nephropathy–like kidney disease in miR-23b−/− and Kawasaki disease mice, while mesangial IgA and C3 deposition failed to develop in Trdmt1−/− miR-23b−/− mice. By contrast, increased m5C RNA modification resulted in an exaggerated IgA nephropathy phenotype. miR-23b regulation of serum IgA levels and the development of an IgA nephropathy–like kidney disease in miR-23b−/− and Kawasaki disease mice is likely mediated through TRDMT1-driven 5mC RNA modification in B cells, resulting in impaired activation-induced cytidine deaminase activity and IgA class switch recombination. CONCLUSIONS: This study revealed TRDMT1-induced RNA 5mC methylation regulated IgA class switch, and inhibition of RNA 5mC by 5-azacytidine ameliorated progression of IgA nephropathy.
引用
- Yu S, Li X, Wang T, et al. B-Cell Epigenetic Modulation of IgA Response by 5-Azacytidine and IgA Nephropathy. J Am Soc Nephrol. 2024. PMID: 39137052. doi:10.1681/ASN.0000000000000441
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。